| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| E797641 | 254750-02-2 | Emricasan, 10mM in DMSO Emricasan, 10mM in DMSO |
C26H27F4N3O7 | |
| E879996 | 254750-02-2 | Emricasan, ≥99% Emricasan, ≥99% |
C26H27F4N3O7 | |
| E881664 | 1638526-21-2 | EMT inhibitor-1 , ≥98% EMT inhibitor-1 , ≥98% |
C12H12Cl2N2O2S | |
| E938059 | 152128-77-3 | Emtricitabine sulfoxide, ≥98% Emtricitabine S-oxide, ≥98% |
C8H10FN3O4S | |
| E878817 | 496807-64-8 | EN460 , 98% EN460 , 98% |
C22H12ClF3N2O4 | |
| E879432 | 349554-02-5 | Enalapril D5 maleate, 98% Enalapril D5 maleate, 98% |
C24H27D5N2O9 | |
| E883026 | 1356922-29-6 | Enalaprilat D5 Sodium Salt, 98% Enalaprilat D5 Sodium Salt, 98% |
C18H17D5N2Na2O5 | |
| E793267 | 1446502-11-9 | Enasidenib (AG-221), 10mM in DMSO Enasidenib (AG-221), 10mM in DMSO |
C19H17F6N7O | |
| E872863 | 1446502-11-9 | Enasidenib (AG-221), 99% Enasidenib (AG-221), 99% |
C19H17F6N7O | |
| E881630 | 1650550-25-6 | Enasidenib mesylate, ≥99% Enasidenib mesylate, ≥99% |
C20H21F6N7O4S | |
| E884680 | 107361-33-1 | Enazadrem , ≥97% Enazadrem , ≥97% |
C18H25N3O | |
| E878496 | 550999-74-1 | Encenicline hydrochloride, ≥98% Encenicline hydrochloride, ≥98% |
C16H18Cl2N2OS | |
| E872422 | 1269440-17-6 | Encorafenib (LGX818), 99% Encorafenib (LGX818), 99% |
C22H27ClFN7O4S | |
| E883454 | 1276124-00-5 | Endomorphin 2 TFA , 98% Endomorphin 2 TFA , 98% |
C34H38F3N5O7 | |
| E879911 | 265646-85-3 | Endovion, 99% Endovion, 99% |
C16H9BrF6N6O | |
| E884074 | 1197194-61-8 | Endoxifen E-isomer hydrochloride, ≥98% Endoxifen E-isomer hydrochloride, ≥98% |
C25H28ClNO2 | |
| E879967 | 259525-01-4 | Enecadin , 98% Enecadin , 98% |
C21H28FN3O | |
| E880498 | 211813-86-4 | Eniporide hydrochloride, ≥99% Eniporide hydrochloride, ≥99% |
C14H17ClN4O3S | |
| E794799 | 934353-76-1 | ENMD-2076, 10mM in DMSO ENMD-2076, 10mM in DMSO |
C21H25N7 | |
| E861088 | 934353-76-1 | ENMD-2076, >98% ENMD2076, >98% |
C21H25N7 |